We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome (ASAPIII)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02067910
Recruitment Status : Completed
First Posted : February 20, 2014
Last Update Posted : August 28, 2019
Bristol-Myers Squibb
Information provided by (Responsible Party):
Dr. H. Bootsma, University Medical Center Groningen